Venetoclax-Azacitidine As Salvage Therapy and Bridge to Allogeneic Cell Transplantation in Relapsed/Refractory AML Compared to Historical Data of the SAL Registry Study

被引：3
|
作者：
Unglaub, Julia M.
Schlenk, Richard F.
Hanoun, Maher
Reinhardt, H. Christian
Middeke, Jan Moritz
Schaefer-Eckart, Kerstin
Steffen, Bjoern
Krause, Stefan W.
Schliemann, Christoph
Kaufmann, Martin
Haenel, Mathias
Jost, Edgar
Crysandt, Martina
Fransecky, Lars
Kraus, Sabrina
Einsele, Hermann
Niemann, Dirk
Neubauer, Andreas
Seggewiss-Bernhardt, Ruth
Scholl, Sebastian
Klein, Stefan
Schmid, Christoph
Schaich, Markus
Platzbecker, Uwe
Baldus, Claudia D.
Bornhaeuser, Martin
Serve, Hubert
Rollig, Christoph
Kramer, Michael
Katelari, Elena
Janssen, Maike
Pabst, Caroline
Luft, Thomas
Dreger, Peter
Mueller-Tidow, Carsten
Sauer, Tim
机构：
[1] Univ Hosp Heidelberg, Dept Hematol Oncol & Rheumatol, Heidelberg, Germany
[2] Natl Ctr Tumor Dis, NCT Trial Ctr, German Canc Res Ctr, Heidelberg, Germany
[3] Univ Hosp Essen, Dept Hematol & Stem Cell Transplantat, Essen, Germany
[4] Univ Hosp Dresden, Dept Internal Med 1, Dresden, Germany
[5] Hosp Nurnberg, Dept Internal Med 5, Nurnberg, Germany
[6] Univ Hosp Frankfurt Main, Dept Hematol & Oncol, Frankfurt, Germany
[7] Univ Hosp Erlangen, Dept Hematol & Med Oncol, Erlangen, Germany
[8] Univ Hosp Muenster, Dept Med Hematol Oncol & Pneumol A, Munster, Germany
[9] Robert Bosch Krankenhaus, Dept Hematol Oncol & Palliat Med, Stuttgart, Germany
[10] Chemnitz Hosp, Dept Internal Med 3, Chemnitz, Germany
[11] Rhein Westfal TH Aachen, Univ Hosp, Fac Med, Dept Hematol Oncol Hemostaseol & Stem Cell Transp, Aachen, Germany
[12] Univ Hosp Schleswig Holstein, Dept Internal Med 2, Kiel, Germany
[13] Univ Hosp Wuerzburg, Dept Med 2, Wurzburg, Germany
[14] Ev Stift St Martin, Dept Hematol Oncol & Palliat Med, Koblenz, Germany
[15] Univ Hosp Marburg, Dept Hematol Oncol & Immunol, Marburg, Germany
[16] Sozial Stiftung Bamberg, Dept Hematol Oncol, Bamberg, Germany
[17] Univ Hosp Jena, Jena, Germany
[18] Univ Hosp Mannheim, Dept Hematol & Oncol, Mannheim, Germany
[19] Univ Hosp Augsburg, Dept Hematol & Oncol, Augsburg, Germany
[20] Rems Murr Klinikum Winnenden, Dept Hematol Oncol & Palliat Med, Winnenden, Germany
[21] Univ Hosp Leipzig, Leipzig, Germany
[22] Univ Hosp, Dept Internal Med 1, Dresden, Germany
[23] Univ Hosp Heidelberg, Internal Med Hematol Oncol & Rheumatol 5, Heidelberg, Germany
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-151287
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4418
引用
收藏
页数：7
相关论文
共 50 条
  • [1] Venetoclax-based therapy as a bridge to allogeneic hematopoietic cell transplantation in children with relapsed/refractory AML
    Thomas Pfeiffer
    Ying Li
    Emily Ashcraft
    Seth E. Karol
    Jeffrey E. Rubnitz
    Rebecca Epperly
    Renee Madden
    Ewelina Mamcarz
    Esther Obeng
    Amr Qudeimat
    Akshay Sharma
    Ashok Srinivasan
    Ali Suliman
    Aimee C. Talleur
    M. Paulina Velasquez
    Stephen Gottschalk
    Brandon M. Triplett
    Swati Naik
    Bone Marrow Transplantation, 2023, 58 : 328 - 331
  • [2] Venetoclax-based therapy as a bridge to allogeneic hematopoietic cell transplantation in children with relapsed/refractory AML
    Pfeiffer, Thomas
    Li, Ying
    Ashcraft, Emily
    Karol, Seth E.
    Rubnitz, Jeffrey E.
    Epperly, Rebecca
    Madden, Renee
    Mamcarz, Ewelina
    Obeng, Esther
    Qudeimat, Amr
    Sharma, Akshay
    Srinivasan, Ashok
    Suliman, Ali
    Talleur, Aimee C.
    Velasquez, M. Paulina
    Gottschalk, Stephen
    Triplett, Brandon M.
    Naik, Swati
    BONE MARROW TRANSPLANTATION, 2023, 58 (03) : 328 - 331
  • [3] Venetoclax-azacitidine as salvage therapy for relapsed mixed phenotype acute leukemia after a second allogeneic hematopoietic stem cell transplantation: a case report
    Mekni, Sabrine
    Kanoun, Rimmel Yosra
    Ladeb, Saloua
    Belloumi, Dorra
    Ben Abdeljelil, Nour
    Ben Othman, Tarek
    BLOOD RESEARCH, 2023, 58 (02) : 118 - 120
  • [4] Salvage use of venetoclax-based therapy for relapsed AML post allogeneic hematopoietic cell transplantation
    Maansi Joshi
    Joselle Cook
    Kristen McCullough
    Ahmad Nanaa
    Naseema Gangat
    James M. Foran
    Hemant S. Murthy
    Mohamed A. Kharfan-Dabaja
    Lisa Sproat
    Jeanne Palmer
    Animesh Pardanani
    Ayalew Tefferi
    Kebede Begna
    Michelle Elliot
    Aref Al-Kali
    Mrinal Patnaik
    Mithun V. Shah
    William J. Hogan
    Mark R. Litzow
    Hassan B. Alkhateeb
    Blood Cancer Journal, 11
  • [5] Salvage use of venetoclax-based therapy for relapsed AML post allogeneic hematopoietic cell transplantation
    Joshi, Maansi
    Cook, Joselle
    McCullough, Kristen
    Nanaa, Ahmad
    Gangat, Naseema
    Foran, James M.
    Murthy, Hemant S.
    Kharfan-Dabaja, Mohamed A.
    Sproat, Lisa
    Palmer, Jeanne
    Pardanani, Animesh
    Tefferi, Ayalew
    Begna, Kebede
    Elliot, Michelle
    Al-Kali, Aref
    Patnaik, Mrinal
    Shah, Mithun V.
    Hogan, William J.
    Litzow, Mark R.
    Alkhateeb, Hassan B.
    BLOOD CANCER JOURNAL, 2021, 11 (03)
  • [6] EFFICACY OF VENETOCLAX/AZACITIDINE SALVAGE THERAPY COMPARED TO AZACITIDINE MONOTHERAPY FOR PATIENT WITH FIRST RELAPSED OR REFRACTORY ACUTE MYELOID LEUKAEMIA
    Petit, C.
    Mohty, B.
    Hicheri, Y.
    Saillard, C.
    Villetard, F.
    Maisano, V.
    Charbonnier, A.
    Rey, J.
    D'Incan, E.
    Vey, N.
    Hospital, M. -A.
    Garciaz, S.
    ANNALS OF HEMATOLOGY, 2023, 102 (SUPPL 1) : S53 - S54
  • [7] Clofarabine Salvage Therapy Prior to Allogeneic Hematopoietic Cell Transplantation in Patients with Relapsed or Refractory AML - Interim Results of the Bridge Trial
    Middeke, Jan Moritz
    Parmentier, Stefani
    Alakel, Nael
    Schaich, Markus
    Thiede, Christian
    Platzbecker, Uwe
    Roellig, Christoph
    Haenel, Mathias
    Stuhler, Gernot
    Morgner, Anke
    Eulenstein, Uta
    Ehninger, Gerhard
    Bornhaeuser, Martin
    Schetelig, Johannes
    BLOOD, 2012, 120 (21)
  • [8] Clofarabine salvage therapy before allogeneic hematopoietic stem cell transplantation in patients with relapsed or refractory AML: results of the BRIDGE trial
    J M Middeke
    R Herbst
    S Parmentier
    G Bug
    M Hänel
    G Stuhler
    K Schäfer-Eckart
    W Rösler
    S Klein
    W Bethge
    U Bitz
    B Büttner
    H Knoth
    N Alakel
    M Schaich
    A Morgner
    M Kramer
    K Sockel
    M von Bonin
    F Stölzel
    U Platzbecker
    C Röllig
    C Thiede
    G Ehninger
    M Bornhäuser
    J Schetelig
    Leukemia, 2016, 30 : 261 - 267
  • [9] Clofarabine salvage therapy before allogeneic hematopoietic stem cell transplantation in patients with relapsed or refractory AML: results of the BRIDGE trial
    Middeke, J. M.
    Herbst, R.
    Parmentier, S.
    Bug, G.
    Haenel, M.
    Stuhlers, G.
    Schaefer-Eckart, K.
    Roester, W.
    Klein, S.
    Bethge, W.
    Bitz, U.
    Buettner, B.
    Knoth, H.
    Alakel, N.
    Schaich, M.
    Morgner, A.
    Kramer, M.
    Sockel, K.
    von Bonin, M.
    Stoelzel, F.
    Platzbecker, U.
    Roellig, C.
    Thiede, C.
    Ehninger, G.
    Bornhaeuser, M.
    Schetelig, J.
    LEUKEMIA, 2016, 30 (02) : 261 - 267
  • [10] Venetoclax-based combination therapy as a bridge to allogeneic hematopoietic cell transplant in children with relapsed/refractory AML
    Pfeiffer, Thomas
    Li, Ying
    Karol, Seth E.
    Rubnitz, Jeffrey E.
    Epperly, Rebecca
    Madden, Renee
    Mamcarz, Ewelina
    Obeng, Esther A.
    Qudeimat, Amr
    Sharma, Akshay
    Srinivasan, Ashok
    Suliman, Ali
    Talleur, Aimee C.
    Velasquez, Mireya Paulina
    Gottschalk, Stephen
    Triplett, Brandon M.
    Naik, Swati
    PEDIATRIC BLOOD & CANCER, 2022, 69
12345